Lupus Research Program
The Lupus Research Program funds innovative, clinically relevant research to advance understanding and treatment of lupus, emphasizing near-term impact, biological mechanisms, and patient quality of life.
Funder: Military Health System Research Program
Due Dates (Anticipated): September 2026 (Full application deadline; projected)
Funding Amounts: Up to $2 million total costs over 4 years (Transformative Vision Award); other mechanisms range from $250,000–$1 million.
Summary: Supports innovative, high-impact lupus research to improve understanding, treatment, and quality of life for individuals with lupus.
Key Information: This is a forecasted opportunity; final details and deadlines will be announced later.
Description
The Lupus Research Program (LRP), managed by the Congressionally Directed Medical Research Programs (CDMRP) under the Department of Defense, funds innovative research with clinical relevance to better understand, prevent, diagnose, and treat lupus, while improving the quality of life for those living with the disease. The Transformative Vision Award (TVA) mechanism specifically supports research that implements interventions at the individual or healthcare system level, aiming for near-term impact on health-related quality of life for people with lupus. Applicants are encouraged to address disease heterogeneity, biological mechanisms, end organ injury, genetic and epigenetic factors, and innovative healthcare delivery models. Consumer advocate involvement is required for some mechanisms.
